ADHERE trial - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Representative image of a subcutaneous injection being administered to a patient, reflecting the self-injection option available with VYVGART SC for CIDP treatment

Read More

Pharma Industry News

argenx wins EU approval for subcutaneous VYVGART in CIDP, ending 30-year innovation drought in treatment

argenx gains EU approval for subcutaneous VYVGART in CIDP, reshaping autoimmune neurology care with a novel self-injection biologic.

byPallavi Madhiraju

June 21, 2025

web analytics